Form 4: CervoMed Director Sylvie Gregoire Acquires Stock Options

Director Sylvie Gregoire received stock options for 5,750 shares of CervoMed Inc. common stock following election to the board.

Summary

• Sylvie Gregoire, a director of CervoMed Inc., was granted stock options to purchase 5,750 shares of the company's common stock on June 14, 2024.
• The grant was made in connection with Gregoire's election to the Issuer's board of directors at its 2024 Annual Meeting of Stockholders.
• The options were granted under the Issuer's 2015 Equity Incentive Plan, as amended, in accordance with the terms of the Issuer's non-employee director compensation policy.
• The exercise price of the stock options is $19.01.
• The shares will vest monthly over a one-year period, beginning June 30, 2024, subject to continued service.

Sentiment

Score: 7

Explanation: The document reflects a standard corporate governance practice of compensating directors with stock options, which is generally viewed positively as it aligns interests with shareholders.

Positives

• The granting of stock options to a new director aligns their interests with those of the shareholders.
• The vesting schedule incentivizes continued service and commitment to the company.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the stock options.

Industry Context

Stock option grants are a common form of compensation for directors, aligning their interests with shareholders and incentivizing company performance. This is a standard practice in publicly traded companies.

Comparison to Industry Standards

• Director compensation packages vary widely across the biotechnology industry, but stock options are a common component.
• Comparable companies often use a mix of cash retainers, equity grants, and meeting fees to compensate non-employee directors.
• The size of the grant is likely benchmarked against peer companies of similar size and stage of development.

Stakeholder Impact

• Shareholders may view the stock option grant positively as it incentivizes the director to work towards increasing shareholder value.
• The director benefits from the potential future value of the stock options.

Key Dates